赛多利斯完成收购MatTek，进一步扩充细胞技术产品线

Core Viewpoint - Sartorius has expanded its cell technology product line by integrating MatTek into its laboratory products and services division, creating synergies with existing drug development solutions, including cell analysis instruments, reagents, and AI models [1][2]. Group 1: Acquisition Details - Sartorius officially completed the acquisition of MatTek, a subsidiary of BICO Group, on July 1, 2025 [2]. - The acquisition aims to enhance Sartorius's capabilities in cell technology and drug development [2]. Group 2: MatTek Overview - MatTek is a leading developer and manufacturer of human cell microtissues and three-dimensional models, focused on accelerating drug development processes [3]. - The advanced cell models developed by MatTek simulate the structure and function of human tissues, providing more accurate, cost-effective, and reproducible results compared to traditional two-dimensional cell cultures, while also reducing the need for animal testing [3]. - MatTek employs over 80 staff and is headquartered in Ashland, Massachusetts, with a production facility in Bratislava, Slovakia [3].